Atlas Trials

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines

Clinical trial NCT00004799 · COMPLETED

Trial details

NCT number
NCT00004799
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pertussis
Start date
1991-04-01
Enrollment
10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.